Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.22.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue    
Revenue $ 68,941 $ 55,297
Cost of revenue    
Cost of revenue 34,972 24,372
Operating expenses    
Selling, general and administrative 27,628 17,521
Depreciation and amortization 13,196 13,114
Total operating expenses 40,824 30,635
Operating income (loss) (6,855) 290
Interest expense, including amortization of deferred financing costs, net 6,624 5,059
Change in fair value of warrant liability (27) (2,424)
Loss before income taxes (13,452) (2,345)
Income tax expense (benefit)    
Current 1,306 102
Deferred (3,851) (1,366)
Total income tax benefit (2,545) (1,264)
Net loss attributable to the Company $ (10,907) $ (1,081)
Loss per share:    
Basic $ (0.15) $ (0.27)
Diluted $ (0.15) $ (0.27)
Weighted average number of shares outstanding:    
Basic 74,040,261 31,647,131
Diluted 74,040,261 31,647,131
Service    
Revenue    
Revenue $ 47,506 $ 45,062
Cost of revenue    
Cost of revenue 17,529 16,211
Product    
Revenue    
Revenue 21,435 10,235
Cost of revenue    
Cost of revenue $ 17,443 $ 8,161